Medical device distributor and innovator focused on chronic disease management in Italy
Theras operates as a medical device company in Italy serving chronic disease management (neuromodulation, diabetes care, chronic pain), with a sales-led hiring mix—37 of 91 open roles in sales versus 7 in engineering—indicating a distribution and market-access model rather than a product-development one. Tech stack centers on SAP enterprise systems (S/4HANA, MM, WM, Analytics Cloud) paired with diabetes management integrations (Dexcom, Insulet) and neuromodulation devices (Nevro), suggesting the company sources and distributes partner products alongside internal offerings. Active adoption of these device integrations signals expansion into new therapeutic areas.
Founded in 2011, Theras provides medical device solutions and technologies for chronic disease management across neuromodulation, diabetes care, and chronic pain treatment in the Italian healthcare market. The company operates across 201–500 employees, headquartered in Salsomaggiore Terme in Emilia-Romagna. Projects reflect a distribution and market-expansion focus: weight management business unit launch, pharmacy channel trade marketing, area plan implementation aligned with national sales targets, and digital technology rollout. Core challenges center on payer negotiations, supply chain optimization, regulatory compliance (MDR), and revenue target achievement—typical friction points for medical device companies navigating reimbursement and regulatory environments.
Primary systems: SAP S/4HANA, SAP MM, SAP WM, and SAP Analytics Cloud for ERP and supply chain. Front-end: Node.js and React. Cloud infrastructure: Microsoft Azure. Database: PostgreSQL. Device integrations: Dexcom and Insulet (diabetes), Nevro (neuromodulation).
Neuromodulation, diabetes care, and chronic pain management. The company is launching a weight management business unit and optimizing existing product lines across these areas.
Other companies in the same industry, closest in size